James Michael O'Donnell

2013 West Virginia University, Morgantown, WV, United States 
 2013- Pharmacy and Pharmaceutical Sciences State University of New York, Buffalo, Buffalo, NY, United States 
Antidepressant drugs
"James M. O'Donnell"
Mean distance: 15.85 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhu MJ, Shi J, Chen Y, et al. (2020) Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior. Psychopharmacology
Cui SY, Yang MX, Zhang YH, et al. (2019) Protection from amyloid β peptide-induced memory, biochemical and morphological deficits by a phosphodiesterase-4D (PDE4D) allosteric inhibitor. The Journal of Pharmacology and Experimental Therapeutics
Zhu X, Li W, Li Y, et al. (2019) The antidepressant- and anxiolytic-like effects of resveratrol: Involvement of phosphodiesterase-4D inhibition. Neuropharmacology
Gurney ME, Nugent RA, Mo X, et al. (2019) Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders. Journal of Medicinal Chemistry
Chen L, Cui S, Yu H, et al. (2019) Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice. Journal of Psychopharmacology (Oxford, England). 269881119832753
Huang X, Xiaokaiti Y, Yang J, et al. (2018) Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior. Neuropharmacology
Zhang C, Xu Y, Chowdhary A, et al. (2018) Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Shi J, Liu H, Pan J, et al. (2018) Inhibition of phosphodiesterase 2 by Bay 60-7550 decreases ethanol intake and preference in mice. Psychopharmacology
Huang XF, Jiang WT, Liu L, et al. (2018) A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling. Cns Neuroscience & Therapeutics
Liu L, Zheng J, Huang XF, et al. (2018) The neuroprotective and antidepressant-like effects of Hcyb1, a novel selective PDE2 inhibitor. Cns Neuroscience & Therapeutics
See more...